• Anticancer research · May 2012

    Clinical Trial

    Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.

    • Hiromichi Matsuoka, Chihiro Makimura, Atsuko Koyama, Masatomo Otsuka, Wataru Okamoto, Yasuhito Fujisaka, Hiroyasu Kaneda, Junji Tsurutani, and Kazuhiko Nakagawa.
    • Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan. matsuoka_h@dotd.med.kindai.ac.jp
    • Anticancer Res. 2012 May 1;32(5):1805-9.

    BackgroundNeuropathic pain frequently occurs in cancer patients, but no drug therapy has been established for this type of disorder. The purpose of this study was to investigate the effect of duloxetine in cancer patients suffering from neuropathic pain.Patients And MethodsThe subjects of the study were 15 cancer patients with neuropathic pain who visited the Kinki University Faculty of Medicine Hospital and met the International Association for the Study of Pain diagnostic criteria for neuropathic pain. Duloxetine was administered to patients in whom pregabalin could not be administered. The influence of duloxetine was investigated retrospectively with the use of a numerical rating scale.ResultsPain was reduced in 7 out of the 15 patients. Sleepiness and the light-headed feeling were improved in four patients, in whom, however, the pain was not reduced. Thus, duloxetine was judged to be effective in 11 patients. The maintenance dose of duloxetine was 20-40 mg/day.ConclusionDuloxetine administration may be effective for neuropathic pain in cancer patients who cannot tolerate pregabalin administration.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…